# ESBRIET
> **NDA208780** · New Drug Application · Sponsor: LEGACY PHARMA · Approved 2017-01-11
## Drug
- **FDA Application Number:** NDA208780
- **Application type:** New Drug Application
- **Brand name:** ESBRIET
- **Generic name:** PIRFENIDONE
- **Active ingredients:** PIRFENIDONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LEGACY PHARMA
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2017-01-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208780)
---
*AI Analytics · CC0 1.0*